Publication Name	World Journal of Gastroenterology
Manuscript ID	18594
Country	Belgium

Received	2015-04-24 16:31
Peer-Review Started	2015-04-24 20:26
To Make the First Decision	2015-06-02 16:08
Return for Revision	2015-06-07 18:00
Revised	2015-06-22 19:52
Second Decision	2015-08-21 13:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-02 15:12
Articles in Press	2015-09-02 15:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-21 14:44
Publish the Manuscript Online	2015-10-19 09:14

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
Manuscript Source	Invited Manuscript
All Author List	Daan Dierickx and Nina Cardinaels
Funding Agency and Grant Number
Corresponding Author	Daan Dierickx, MD, Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. daan.dierickx@uzleuven.be
Key Words	Epstein Barr virus; Liver transplantation; Posttransplant lymphoproliferative disorders
Core Tip	Prevention of organ rejection following solid organ transplantation requires long term immunosuppressive therapy, leading to an increased risk of infections and malignancies. Posttransplant lymphoproliferative disorder (PTLD) comprises one of the most serious complications following trans-plantation with high morbidity and mortality rates. In this article we will review the different aspects on PTLD following liver transplantation.
Publish Date	2015-10-19 09:14
Citation	Dierickx D, Cardinaels N. Posttransplant lymphoproliferative disorders following liver transplantation: where are we now? World J Gastroenterol 2015; 21(39): 11034-11043
URL	http://www.wjgnet.com/1007-9327/full/v21/i39/11034.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i39.11034

Full Article (PDF)	WJG-21-11034.pdf
Full Article (Word)	WJG-21-11034.doc
Manuscript File	18594-Review.docx
Answering Reviewers	18594-Answering reviewers.pdf
Audio Core Tip	18594-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18594-Conflict-of-interest statement.pdf
Copyright License Agreement	18594-Copyright assignment.pdf
Peer-review Report	18594-Peer-review(s).pdf
Scientific Misconduct Check	18594-Scientific misconduct check.pdf
Scientific Editor Work List	18594-Scientific editor work list.pdf